Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ACHC Stock Forecast 2026-2027
$11.68
Current Price
$1.06B
Market Cap
Buy 8
Hold 5
Sell 1
Wall St Analyst Ratings
Distance to ACHC Price Targets
+191.1%
To High Target of $34.00
+58.4%
To Median Target of $18.50
+11.3%
To Low Target of $13.00
ACHC Price Momentum
-11.7%
1 Week Change
-18.9%
1 Month Change
-73.3%
1 Year Change
-17.7%
Year-to-Date Change
-74.4%
From 52W High of $45.61
+2.2%
From 52W Low of $11.43
📊 TOP ANALYST CALLS
Did ACHC Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Acadia Healthcare is one of their latest high-conviction picks.
Latest ACHC Stock Price Targets & Analyst Predictions
Based on our analysis of 26 Wall Street analysts, ACHC has a bullish consensus with a median price target of $18.50 (ranging from $13.00 to $34.00). The overall analyst rating is Buy (7.9/10). Currently trading at $11.68, the median forecast implies a 58.4% upside. This outlook is supported by 8 Buy, 5 Hold, and 1 Sell ratings.
Conversely, the most conservative target is provided by Kevin Fischbeck at B of A Securities, suggesting a 11.3% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ACHC Analyst Ratings
8
Buy
5
Hold
1
Sell
ACHC Price Target Range
Low
$13.00
Average
$18.50
High
$34.00
Current: $11.68
Latest ACHC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ACHC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 16, 2026 | TD Cowen | Ryan Langston | Buy | Maintains | $22.00 |
| Jan 14, 2026 | RBC Capital | Ben Hendrix | Outperform | Maintains | $17.00 |
| Dec 18, 2025 | Mizuho | Ann Hynes | Neutral | Maintains | $17.00 |
| Dec 4, 2025 | Barclays | Andrew Mok | Equal-Weight | Maintains | $14.00 |
| Dec 3, 2025 | Deutsche Bank | Pito Chickering | Buy | Maintains | $20.00 |
| Dec 3, 2025 | UBS | Andrew Mok | Buy | Maintains | $24.00 |
| Dec 3, 2025 | Leerink Partners | Whit Mayo | Market Perform | Downgrade | $14.00 |
| Dec 3, 2025 | Cantor Fitzgerald | Sarah James | Neutral | Maintains | $17.00 |
| Dec 3, 2025 | RBC Capital | Ben Hendrix | Outperform | Maintains | $19.00 |
| Dec 3, 2025 | B of A Securities | Kevin Fischbeck | Underperform | Downgrade | $13.00 |
| Dec 3, 2025 | Keybanc | Matthew Gillmor | Overweight | Maintains | $25.00 |
| Nov 18, 2025 | Keybanc | Matthew Gillmor | Overweight | Maintains | $30.00 |
| Nov 12, 2025 | RBC Capital | Ben Hendrix | Outperform | Maintains | $22.00 |
| Nov 10, 2025 | Guggenheim | Jason Cassorla | Buy | Maintains | $27.00 |
| Nov 7, 2025 | Cantor Fitzgerald | Sarah James | Neutral | Maintains | $22.00 |
| Nov 7, 2025 | UBS | Andrew Mok | Buy | Maintains | $28.00 |
| Nov 6, 2025 | Barclays | Andrew Mok | Equal-Weight | Maintains | $17.00 |
| Oct 8, 2025 | Keybanc | Matthew Gillmor | Overweight | Maintains | $35.00 |
| Oct 7, 2025 | Cantor Fitzgerald | Sarah James | Neutral | Reiterates | $25.00 |
| Oct 3, 2025 | Raymond James | John Ransom | Outperform | Maintains | $30.00 |
Acadia Healthcare Company, Inc. (ACHC) Competitors
The following stocks are similar to Acadia Healthcare based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Acadia Healthcare Company, Inc. (ACHC) Financial Data
Acadia Healthcare Company, Inc. has a market capitalization of $1.06B with a P/E ratio of 10.1x. The company generates $3.27B in trailing twelve-month revenue with a 3.3% profit margin.
Revenue growth is +4.4% quarter-over-quarter, while maintaining an operating margin of +14.0% and return on equity of +3.7%.
Valuation Metrics
Market Cap
$1.06B
Enterprise Value
$3.58B
P/E Ratio
10.1x
PEG Ratio
-0.2x
Price/Sales
0.3x
Growth & Margins
Revenue Growth (YoY)
+4.4%
Gross Margin
+96.4%
Operating Margin
+14.0%
Net Margin
+3.3%
EPS Growth
-46.8%
Financial Health
Cash/Price Ratio
+11.0%
Current Ratio
1.4x
Debt/Equity
74.5x
ROE
+3.7%
ROA
+4.5%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Acadia Healthcare Company, Inc. (ACHC) Business Model
About Acadia Healthcare Company, Inc.
What They Do
Provides behavioral healthcare services in multiple facilities.
Business Model
Acadia Healthcare operates a network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics, and therapeutic school-based programs, generating revenue through the provision of mental health and addiction treatment services. The company focuses on quality care and caters to a growing demand for mental health services, allowing it to capitalize on the increasing acceptance and need for such care in society.
Additional Information
With operations in both the United States and the United Kingdom, Acadia Healthcare is positioned to address the needs of underserved patient populations. The company also collaborates with government health agencies to enhance access to care, making its services more significant as public awareness and acceptance of mental health issues grow.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
19,192
CEO
Mr. Christopher Howal Hunter
Country
United States
IPO Year
1994
Website
www.acadiahealthcare.comAcadia Healthcare Company, Inc. (ACHC) Latest News & Analysis
Latest News
Quick Summary
Acadia Healthcare (ACHC) presented at the 44th Annual J.P. Morgan Healthcare Conference, highlighting its strategic initiatives and performance in the healthcare sector.
Why It Matters
Acadia Healthcare's presentation at a major healthcare conference can signal growth prospects and strategic direction, influencing investor sentiment and stock performance.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Acadia Healthcare (NASDAQ: ACHC) will participate in the J.P. Morgan Healthcare Conference from January 12-15, 2026, with an online webcast of its presentation on January 13 at 5:15 PM PT.
Why It Matters
Acadia Healthcare's participation in a major healthcare conference signals potential insights into its strategy and performance, influencing investor sentiment and stock valuation.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Engine Capital Management acquired approximately 2.6 million shares of Acadia Healthcare for $64 million in Q3, representing 7.6% of its U.S. equity assets.
Why It Matters
Engine Capital Management's significant investment in Acadia Healthcare signals confidence in the company's growth potential, potentially influencing market perception and stock performance.
Source: The Motley Fool
Market Sentiment:
Negative
Quick Summary
Acadia Healthcare (NASDAQ: ACHC) shares fell over 10% after being downgraded to 'Underperform' by Bank of America, citing rising costs impacting profitability through 2026. Price target lowered to $13.
Why It Matters
Acadia Healthcare's downgrade signals increased financial risk due to rising costs, impacting profitability and share value, which may lead to further declines in stock performance.
Source: Proactive Investors
Market Sentiment:
Negative
Quick Summary
Glancy Prongay & Murray LLP is investigating Acadia Healthcare Company (NASDAQ: ACHC) for potential violations of federal securities laws, inviting affected investors to pursue claims.
Why It Matters
Acadia Healthcare's potential legal issues may lead to financial losses for investors, affecting stock performance and confidence in the company's governance and compliance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Acadia Healthcare Company is under investigation for potential violations of federal securities laws, which may affect investors who incurred losses.
Why It Matters
Acadia Healthcare is under investigation for potential federal securities law violations, which may indicate financial instability and impact stock value, raising concerns for current and potential investors.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About ACHC Stock
What is Acadia Healthcare Company, Inc.'s (ACHC) stock forecast for 2026?
Based on our analysis of 26 Wall Street analysts, Acadia Healthcare Company, Inc. (ACHC) has a median price target of $18.50. The highest price target is $34.00 and the lowest is $13.00.
Is ACHC stock a good investment in 2026?
According to current analyst ratings, ACHC has 8 Buy ratings, 5 Hold ratings, and 1 Sell ratings. The stock is currently trading at $11.68. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ACHC stock?
Wall Street analysts predict ACHC stock could reach $18.50 in the next 12 months. This represents a 58.4% increase from the current price of $11.68. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Acadia Healthcare Company, Inc.'s business model?
Acadia Healthcare operates a network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics, and therapeutic school-based programs, generating revenue through the provision of mental health and addiction treatment services. The company focuses on quality care and caters to a growing demand for mental health services, allowing it to capitalize on the increasing acceptance and need for such care in society.
What is the highest forecasted price for ACHC Acadia Healthcare Company, Inc.?
Price targets from Wall Street analysts for ACHC are not currently available. The stock is trading at $11.68.
What is the lowest forecasted price for ACHC Acadia Healthcare Company, Inc.?
The lowest price target for ACHC is $13.00 from Kevin Fischbeck at B of A Securities, which represents a 11.3% increase from the current price of $11.68.
What is the overall ACHC consensus from analysts for Acadia Healthcare Company, Inc.?
The overall analyst consensus for ACHC is bullish. Out of 26 Wall Street analysts, 8 rate it as Buy, 5 as Hold, and 1 as Sell, with a median price target of $18.50.
How accurate are ACHC stock price projections?
Stock price projections, including those for Acadia Healthcare Company, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: January 19, 2026 5:16 AM UTC